March 3rd 2023
Retail giant expanding into two new states, with additional growth in Texas.
February 27th 2023
A conversation with AAFP President Tochi Iroku-Malize, M.D., M.P.H., M.B.A.
February 14th 2023
Steps toward improvement include more access to primary care.
February 8th 2023
BD says results could be available within two hours.
January 31st 2023
Abrupt cutoff ‘would create wide-ranging chaos’ in health care, White House says.
22 states contest COVID-19 vaccine mandate for health care workers
Attorneys general file petition to withdraw requirement.
HHS extends COVID-19 public health emergency into 2023
Administration pushes for vaccines and boosters for the fall.
FDA gives nod to COVID boosters for children as young as 5
Agency seeks to reduce exposure risks as in-person schooling resumes
Fewer children than adults getting COVID-19 vaccinations
Study links discrepancy to adults’ misbeliefs about vaccine safety
September, October prime time for flu vaccines and COVID-19 boosters
AAFP president discusses endorsement, patient approaches, next round of shots.
AMA publishes new codes for updated COVID-19 vaccines, boosters
Four for adult vaccines effective immediately, four pending approval for youths.
Moderna set to sue Pfizer, BioNTech for patent violations in COVID-19 vaccine
Company claims rivals copied proprietary mRNA technology to make shots.
Primary care physicians must listen, educate, vaccinate
Back-to-school season is prime time to reach parents and children about immunizations.
New billing codes for monkeypox testing, vaccines unveiled
Codes enable billing for lab tests, administering vaccines
Realizing a society free of vaccine-preventable diseases
The pandemic underscored the incredible power of vaccination.
Pfizer extending EUA submission for young juvenile COVID-19 vaccine
The move will delay the vaccine’s authorization for this younger group.
Pfizer submits for under age of 5 COVID-19 vaccine EUA
An EUA for the smaller shots would plug a hole in the nation’s vaccination strategy.
FDA approves Moderna COVID-19 vaccine
Spikevax is now the second COVID-19 vaccine approved by US regulators.
Moderna says booster effective against Omicron
The company says a third dose of their COVID-19 vaccine is effective against the latest variant of the disease.
Large portion of hospital personnel still unvaccinated against COVID-19
Nearly a third of hospital personnel had still not been vaccinated against COVID-19 by mid-September.
Pfizer, Moderna COVID-19 boosters get greenlight for all adults from FDA
The move comes just in time for the holiday travel season.
FDA reportedly close to authorizing Pfizer COVID-19 boosters for all adults
The administration is also reportedly planning on purchasing millions of doses of the company’s antiviral pill.
Pfizer seeking expanded COVID-19 booster EUA
The company is asking the FDA to make the additional shots available to anyone 18 years old or older.
Vaccine mandate: Biden administration files response to stay
Wrangling over the requirement continues in the courts.
White House gears up for COVID-19 vaccine mandate court battle
After a panel federal judges put a temporary halt on the mandate, the U.S. Surgeon General says the administration is ready to fight for the requirement.
Biden administration requiring healthcare workers to receive COVID-19 vaccine
The regulation would affect more than 17 million healthcare workers.
CDC recommends Pfizer COVID-19 vaccine for children 5 to 11
The agency moved quickly to approve the smaller shots.
FDA authorizes COVID-19 vaccine for children aged 5 to 11
The vaccine is just awaiting a recommendation from the CDC before they can be rolled out.
FDA panel recommends Pfizer COVID-19 vaccine for children
A previous analysis found the vaccine was 90.7 percent effective against severe COVID-19.
Pfizer touts efficacy of COVID-19 vaccine in ages 5 to 11
The FDA is expected to act on an EUA application for the smaller doses next week.
White House lays out primary care’s role in juvenile COVID-19 vaccinations
The administration sees pediatricians and primary care physicians taking the lead in the push.
FDA expected to allow mix and match COVID-19 boosters
The agency is expected to decide on that as well as Moderna and Johnson and Johnson boosters this week.
UPDATED: FDA recommends Moderna, Johnson and Johnson COVID-19 boosters
The advisory panel is also scheduled to discuss Merck antiviral pill late next month.
FDA panel discussing Moderna COVID-19 boosters
A recommendation is expected on whether the shot should be authorized.
White House report: COVID-19 vaccine mandates working
The Biden administration says that vaccination mandates are not leading to the mass resignations in health that some expected.
2 Clarke Drive Cranbury, NJ 08512